Neuron Guard Srl

02/02/2026

✅ 𝐁𝐁𝐂 - 𝐁𝐫𝐚𝐢𝐧 𝐜𝐨𝐨𝐥𝐢𝐧𝐠 𝐜𝐨𝐥𝐥𝐚𝐫 𝐭𝐫𝐢𝐚𝐥 𝐟𝐨𝐫 𝐡𝐞𝐚𝐝 𝐢𝐧𝐣𝐮𝐫𝐲 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 ✅

We are pleased to share a significant feature by BBC News highlighting the world-first clinical study of Neuron Guard’s brain cooling collar, an innovative approach to targeted cerebral temperature management designed to improve outcomes for patients with severe traumatic brain injury.

Cambridge University Hospitals NHS Foundation Trust, which runs Addenbrooke’s Hospital, said it would be the "𝒘𝒐𝒓𝒍𝒅'𝒔 𝒇𝒊𝒓𝒔𝒕 𝒊𝒏-𝒉𝒖𝒎𝒂𝒏 𝒔𝒕𝒖𝒅𝒚" 𝒕𝒐 𝒎𝒆𝒂𝒔𝒖𝒓𝒆 𝒕𝒉𝒆 "𝒑𝒊𝒐𝒏𝒆𝒆𝒓𝒊𝒏𝒈 𝒎𝒆𝒅𝒊𝒄𝒂𝒍 𝒅𝒆𝒗𝒊𝒄𝒆".

We extend our sincere gratitude to Dr. Andrea Lavinio, our Clinical Lead, for his unwavering leadership and clinical expertise in advancing this pioneering research. His contribution has been instrumental in bringing international attention to this important study and furthering our mission to transform care for patients with acute brain injury.

We encourage you to read the interview and learn more about the potential impact of this cutting-edge technology in neuro-critical care.

A leading hospital is testing a new device aimed at reducing swelling after a brain injury.

19/04/2024

🔜 See you in Rome for the latest edition of 𝗜𝘁𝗮𝗹𝘆 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗦𝘂𝗺𝗺𝗶𝘁 𝟮𝟬𝟮𝟰

At , Italian healthcare stakeholders will share insights and best practices to elevate the nation's healthcare system.

The summit will give us the opportunity to connect with key healthcare decision-makers and be part of the conversations that shape the future of healthcare.

🎟 Information and tickets: https://bamberghealth.com/event/italy-healthcare-innovation-summit-2024

📅 April 23rd
📍 Hotel Shangri-La Roma by OMNIA hotels

09/04/2024

𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐈𝐂𝐔'𝐬 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐂𝐚𝐫𝐞 𝐰𝐢𝐭𝐡 𝐚 𝐬𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐥𝐞 𝐭𝐞𝐦𝐩𝐞𝐫𝐚𝐭𝐮𝐫𝐞 𝐦𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐝𝐞𝐯𝐢𝐜𝐞 - written by Enrico Giuliani for Bamberg Health

Introducing a new medical device for targeted temperature management in the Intensive Care Unit (ICU) requires a meticulous approach that prioritizes sustainability in both economic and environmental aspects.

With our medical device CB240_AURORA, we approached the temperature management challenge from a different angle adopting technologies that were used in other sectors and adapting them to a medical application. These technologies are more energy efficient and can be produced locally with additive manufacturing techniques.

Read more in the article below.

Introducing a new medical device for targeted temperature management in the Intensive Care Unit (ICU) requires a meticulous approach that prioritizes sustainability in both economic and environmental aspects.

21/02/2024

Latest news: “National brain and spinal injury research centre to open in Cambridge”

A new centre will open in April to improve care for people with brain and spinal injuries.
The Cambridge HealthTech Research Centre, based at Addenbrooke's Hospital, will develop technology to help both treatment and recovery.
It is one of 14 across England working on solutions for different conditions.

(..) Companies like Cambridge-based NeuronGuard Ltd, will be working with the centre.

"It is effective," said Andrea Lavinio, a neurocritical care consultant at Addenbrooke's. "But it chills the whole body which can lead to chest infections."
NeuronGuard has developed an alternative which is in early trials - a neck collar which only cools the blood as it enters the brain.
Unlike the existing treatment, it is portable enough to be used at the scene of an accident.

Read the full article by BBC 👉 https://www.bbc.com/news/uk-england-cambridgeshire-68278550

There are 14 HealthTech Centres across England, each working on solutions for different conditions.

24/11/2023

Neuron Guard has completed a successful surveillance audit and obtained the ISO Certification 13485.

The certificate of conformity of the company's quality management system to the requirements of - concerns aspects related to Medical Devices - has been released by IMQ S.p.A..

We are committed to collaborating with relevant stakeholders to identify the needs and adapt our product to make it as usable and effective as possible and compliant with all relevant regulations.

28/07/2023

🟣 A Novel Technology for Targeted Brain Temperature Management 🟣 We're thrilled to announce the publication of the first-in-human study on Neurocritical Care❗

Our group has developed a technology - CB240_Aurora - that allows selective brain temperature management with a highly portable device, thus maximizing neuroprotection while minimizing systemic side effects. Thanks to its portability, the technology may also allow the early application of TTM in out-of-hospital settings (i.e., ambulances) and continuity of care when patients are transferred out of the ICU for imaging or emergency surgery.

Here, we report the first-in-human study of the technology, sponsored by a grant from the National Institute for Health and Care Research Brain Injury MedTech Co-operative.

⬇ Full article ⬇

https://link.springer.com/article/10.1007/s12028-023-01800-7

Special thanks to Andrea Lavinio, Erta Beqiri, Ketan Kataria!

28/05/2022

Da non perdere questo tra la nostra cofondatrice e CMO Mary Franzese con Barbara Sala, CEO di Delcon.

12/05/2022

It was a pleasure for us to participate in this mission.

Thank you all for taking us on board and making it real.

Looking forward to the next adventure!

D-Air Lab Eurac Research terraXcube